Authors: Schwendener, RA Friedl, K Depenbrock, H Schott, H Hanauske, AR

Citation: Ra. Schwendener et al., In vitro activity of liposomal N(4)octadecyl-1-beta-D-arabinofurano-sylcytosine (NOAC), a new lipophilic derivative of 1-beta-D-arabino-furanocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells, INV NEW DR, 19(3), 2001, pp. 203-210

Authors: Rank, P Peter, R Depenbrock, H Eisenbrand, G Schmid, P Pitzl, H Hanauske, AR

Citation: P. Rank et al., Preclinical activity of 17 beta-[N-[N '-(2-chloroethyl)-N '-nitrosocarbamoyl]-L-alanyl]-5 alpha-dihydrotesterone (E91) against tumour colony forming units and haematopoietic progenitor cells, EUR J CANC, 35(6), 1999, pp. 1009-1013

Authors: Thodtmann, R Depenbrock, H Dumez, H Blatter, J Johnson, RD van Oosterom, A Hanauske, AR

Citation: R. Thodtmann et al., Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin, J CL ONCOL, 17(10), 1999, pp. 3009-3016

Authors: Thodtmann, R Depenbrock, H Blatter, J Johnson, RD van Oosterom, A Hanauske, AR

Citation: R. Thodtmann et al., Preliminary results of a phase I study with MTA (LY231514) in combination with cisplatin in patients with solid tumors, SEMIN ONCOL, 26(2), 1999, pp. 89-93